Aemetis, Inc. (OTCQB: AMTX), an advanced fuels and renewable chemicals company, announced today that its 50 million gallon per year capacity biodiesel and refined glycerin production facility in Kakinada, India has been upgraded to produce high-quality distilled biodiesel. The Aemetis plant was built in 2008 using advanced technology to produce biodiesel and refined glycerin using large volumes of lower-cost, non-food by-products from the edible oil industry as feedstock to supply the biofuel, pharmaceutical, and industrial markets.
“The new distillation production unit is fully commissioned and the India facility now produces biodiesel meeting or exceeding the highest standards for biodiesel quality worldwide,” according to Sanjeev Gupta, Managing Director of Aemetis’ subsidiary in India, Universal Biofuels Private Ltd.
The Aemetis plant is the only distilled biodiesel producer in India and is one of the only plants in Asia capable of producing large supplies of biodiesel that meet the rigorous European Union (ISCC) standards. During 2013, approximately $20 million of biodiesel was produced by the Aemetis plant in India and delivered to customers in Europe.
“The completion of this biodiesel distillation unit allows Aemetis to significantly expand our production levels in order to supply European and India biodiesel customers,” stated Eric McAfee, Chairman and CEO of Aemetis. “Recently, the European Union adopted five-year, anti-dumping tariffs against Argentina and Indonesia due to large subsidies provided to their local producers. Since an anti-dumping tariff already exists against US biodiesel imports, European fuel customers are now focused on Malaysia and India as the remaining low-cost biodiesel suppliers to Europe. Using lower-cost by-products from the edible oils industry, the Aemetis biodiesel plant in India now has among the lowest cost and highest quality of any biodiesel produced.”
Headquartered in Cupertino, California, Aemetis is an advanced fuels and renewable chemicals company that was founded in 2006. Aemetis owns and operates a 60 million gallon ethanol and 420,000 ton animal feed plant in California that is the first upgraded facility approved by the EPA to produce D5 Advanced Biofuels using the milo/biogas/CHP pathway. Aemetis also built, owns and operates a 50 million gallon capacity renewable chemicals and advanced fuels production facility on the East Coast of India producing high quality, distilled biodiesel and refined glycerin for customers in Europe and Asia. Aemetis operates a research and development laboratory at the Maryland Biotech Center, and holds five granted patents on its Z-microbe and related technology for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
Forward Looking Statements
The information contained herein includes forward-looking statements related to future events. Statements regarding future events are based on current expectations and are necessarily subject to associated risks related to, among other things, the ability of the company to adequately protect our technologies, the availability of resources used for industrial production, and the risk of unforeseen governmental regulatory changes.. Actual results may differ materially from those in the projections or other forward-looking statements made herein. For information regarding other related risks, please see the “Risk Factors” section of the company’s filings with the SEC.
For more information on: Aemetis